Characterization of Publicly Available Lymphoblastoid Cell Lines for Disease-Associated Mutations in 11 Genes-Reference-Cited by-同舟云学术

Characterization of Publicly Available Lymphoblastoid Cell Lines for Disease-Associated Mutations in 11 Genes

Published:2005-11-01 Issue:11 Volume:51 Page:2156-2159
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Bernacki Susan H¹,Beck Jeanne C²,Muralidharan Kasinathan³,Schaefer Frederick V⁴,Shrimpton Antony E⁵,Richie Kristy L⁶,Levin Barbara C⁶,Pont-Kingdon Genevieve⁷,Stenzel Timothy T¹

Affiliation:

1. Department of Pathology, Duke University Medical Center, Durham, NC;

2. Coriell Cell Repositories, Coriell Institute for Medical Research, Camden, NJ;

3. Department of Human Genetics, Emory University School of Medicine, Atlanta, GA;

4. Center for Genetic Testing at Saint Francis, Tulsa, OK;

5. Department of Pathology, State University of New York Upstate Medical University, Syracuse, NY;

6. DNA Technologies Group, National Institute of Standards and Technology, Gaithersburg, MD;

7. ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT

Funder

Abbott Laboratories

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/51/11/2156/32684299/clinchem2156.pdf

Reference24 articles.

1. University of Washington, Seattle. GeneTests. Medical genetics information resource, 1993–2005 [Online Database].http://www.geneclinics.org/ (accessed February 7, 2005)..

2. Williams LO, Cole EC. General recommendations for quality assurance programs for laboratory molecular genetic tests, final monograph1999 Centers for Disease Control and Prevention, Public Health Practice Program Office, Division of Laboratory Services Atlanta, GA. .

3. Williams LO, Cole EC, Lubin IM, Iglesias NI, Jordan RL, Elliott LE. Quality assurance in human molecular genetics testing: status and recommendations. Arch Pathol Med2003;127:1353-1358.

4. Bernacki SH, Stankovic AK, Williams LO, Beck JC, Herndon JE, Snow-Bailey K, et al. Establishment of stably ebv-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing. J Mol Diagn2003;5:227-230.

5. Grody WW. Quest for controls in molecular genetics. J Mol Diagn2003;5:209-211.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B Cells Control Mucosal-Associated Invariant T Cell Responses to Salmonella enterica Serovar Typhi Infection Through the CD85j HLA-G Receptor;Frontiers in Immunology;2021-10-01

2. Global profiling of viral and cellular non-coding RNAs in Epstein–Barr virus-induced lymphoblastoid cell lines and released exosome cargos;Cancer Letters;2017-03

3. Utility of lymphoblastoid cell lines;Journal of Neuroscience Research;2009-07

4. Quantitative Analysis of Epstein-Barr Virus Supernatant by Real-Time PCR Assay;Cell Preservation Technology;2008-03

5. Genetically Characterized Positive Control Cell Lines Derived from Residual Clinical Blood Samples;Clinical Chemistry;2005-11-01